As from June 8, 2018, the equity rights in NeuroVive Pharmaceutical AB, NVP TO
5, will be admitted to trading on the list for Equity rights. Trading will
continue up to and including November 28, 2018.
Security Equity rights
name
--------------------------------------------------------------------------------
Terms: One (1) subscription option entitles to the subscription of one
(1) new share in NeuroVive Pharmaceutical AB.
The subscription price for the shares upon exercise of the
subscription options corresponds to SEK 3.80 per share.
--------------------------------------------------------------------------------
Subscription November 1, 2018 - November 30, 2018
period:
--------------------------------------------------------------------------------
Short name NVP TO 5
--------------------------------------------------------------------------------
Round lot 1
--------------------------------------------------------------------------------
Clearing Bilateral settlement at Euroclear Sweden
--------------------------------------------------------------------------------
ISIN code SE0010948778
--------------------------------------------------------------------------------
Orderbook ID 155747
--------------------------------------------------------------------------------
Market OMX STO Eq.rights,Subs.Opt, Int. shares/1
Segment /
no:
--------------------------------------------------------------------------------
Tick Size / MiFID II tick size table / 230
no:
--------------------------------------------------------------------------------
MIC Code: XSTO
--------------------------------------------------------------------------------
For further information concerning this exchange notice please call Emelie
Thordewall or Cecilia Olsson at + 46 8 405 60 00.© 2018 GlobeNewswire
